Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025

Core Insights - Amicus Therapeutics will participate in several investor conferences in September 2025, highlighting its engagement with the investment community [1][4]. Company Overview - Amicus Therapeutics is a global biotechnology company dedicated to developing high-quality medicines for rare diseases, emphasizing a patient-centric approach [3]. - The company is focused on advancing a pipeline of innovative, first- or best-in-class therapies for rare diseases [3]. Upcoming Events - The company will present at the Cantor Global Healthcare Conference on September 3, 2025, at 10:20 a.m. ET [4]. - Additionally, Amicus Therapeutics will participate in the Morgan Stanley Annual Global Healthcare Conference on September 9, 2025, at 3:20 p.m. ET [4]. - Live audio webcasts of these presentations will be available on the company's investor relations website [2].